Season 2 - Ep. 4: Current indications for CRT - The polypill for CVD prevention

ESC TV Today – Your Cardiovascular News

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

This episode covers:

• Cardiology This Week: A concise summary of recent studies
• Current indications for Cardiac Resynchronisation Therapy
• The polypill for cardiovascular disease prevention
• Snapshots

Host: Perry Elliott

Guests: Carlos Aguiar, Cecilia Linde, Valentin Fuster, Stephan Achenbach

Want to watch that episode? Go to: https://esc365.escardio.org/event/1139

Disclaimer

This programme is intended for health care professionals only and is to be used for educational purposes.

The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

Declarations of interests

Stephan Achenbach, Valentin Fuster and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic.

Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics.

Cecilia Linde has declared to have potential conflicts of interest to report: research grants to institutions; Swedish Heart Lung Foundation, Swedish Academy of Science, Stockholm County Council, Roche Diagnostics. Speaker honoria: AstraZeneca, Medtronic, Impulse Dynamics, Vifor, Novartis, Boehringer Ingelheim, MSD, Bayer Advisory Board, AstraZeneca (continuity study), Medtronic (Women and CRT), Medtronic Implementation of CRT and ICD. DSMB: UCS Uppsala ABC Study.

Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.